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A B S T R A C T 3,3',5'-triiodothyronine, (rT3), is easily measured in human amniotic fluid (AF) during the second and third trimesters. To determine if AF rT3 levels are maintained by either maternal or fetal thyroid function, or both, models offetal hypothyroidism (FH) , maternal hypothyroidism (MH) , and combined maternal and fetal hypothyroidism (MFH) were developed in pregnant rats. Hornone analyses of maternal and fetal serum and AF were performed at term. Thyroxine (T4) and 3,3',5-triiodothyronine (T3) were not detectable in the sera and AF of term fetuses in all groups. MFH rats were prepared by administration of methimazole to the dams, and in some experiments, by maternal thyroidectomy and a low iodine diet as well. In the MFH groups from the three experiments serum thyrotropin (TSH) was markedly elevated in the dams and in the fetuses. FH rats were prepared by administering T4 by various routes to dams treated according to the MFH protocols and serum TSH was elevated in fetal serum. Analysis of FH maternal serum T4, T3, and TSH concentrations suggested mild maternal hyperthyroidism or hypothyroidism depending upon the schedule of T4 administration. The MH groups were prepared by maternal thyroidectomy and in all experiments the fetuses had normal serum TSH concentrations. The degree of maternal hypothyroidism in the MH and MFH groups was equivalent. The mean concentration of AF rT3 in normal rats in three experiments was 28.4+2.5 ng/dl (+SEM) . In the three experiments, AF rT3 was undetectable or markedly reduced in the MH and MFH rats and was normal in the FH rats. These results in
INTRODUCTION
Patients with congenital hypothyroidism have profound retardation of physical, mental, and motor development (1) . A number of workers have sought a means to diagnose congenital hypothyroidism antenatally. In 1975 Chopra and Crandell (2) observed that amniotic fluid (AF) 3,3',5'-triiodothyronine (reverse T3, rT3)1 concentrations were easily detectable during human pregnancy, in contrast to low or undetectable concentrations of thyroxine (T4) and 3,3',5'-triiodothyronine (T3). These observations have been confirmed by others (3) (4) (5) (6) and aroused considerable interest, suggesting that AF rT3 measurements might be a useful means of diagnosing fatal hypothyroidism in utero (7, 8) . ' Abbreviations used in this paper: AF, amniotic fluid; BW, body weight; C group, control group; FH group, fetal hypothyroidism group; LID, low-iodine diet; MFH group, combined maternal-fetal hypothyroidism group; MH group, maternal hypothyroidism group; MMI, methimazole; rT3, reverse T3; T3, 3,3',5-triiodothyronine; T4, thyroxine; TSH, thyrotropin; Tx, thyroidectomized.
Since AF rT3 could be dependent upon either maternal or fetal thyroid function or both, studies were carried out in experimental rat models of fetal hypothyroidism, matemal hypothyroidism, and combined maternal-fetal hypothyroidism. The ovine species was not chosen for these studies since term AF rT3 concentrations are low in the sheep (8) . Previously published rat (9) (10) (11) (12) (13) (14) (15) (16) (17) and primate (18, 19) models of fetal hypothyroidism were not used since hypothyroidism had been induced at birth rather than in the fetus or combined maternal-fetal hypothyroidism resulted from the treatment regimen. When an effort was made to prepare isolated fetal hypothyroidism, pharmacologic doses of T4 were administered to dams receiving antithyroid drugs and/or a low-iodine diet (LID) (20) . Moreover, at the time many of these studies were performed, it was not possible to characterize the hormonal status of mother and fetus by specific and sensitive measurements of T4, T3, and thyrotropin (TSH) concentrations.
In this report several treatment regimens for inducing isolated maternal or fetal hypothyroidism in the rat are described. The hormonal status of these models have been characterized and they have been used to derive information on the source of the relatively large concentration of rT3 in AF. The data demonstrate that reduced AF rT3 in these models are indicative of maternal, rather than fetal, hypothyroidism.
METHODS
Virgin Sprague-Dawley 10-wk old female rats (Charles River Breeding Laboratories, Wilmington, Mass.) were used in these studies. They were cycled and mated in our laboratory (experiment 1) or received from the supplier during the 1st wk of pregnancy (experiments 2 that the LID was not used. In experiment 3 an additional group of MFH rats were studied. These rats received a subcutaneous infusion via osmotic minipump of 10 ,g rT3/100 g body wt (BW) during the last 5 d of pregnancy.
In each experiment, the FH group received identical treatment as the MFH group except that physiologic doses of T4 were administered to the dams. In experiment 1, the FH dams were killed 24 h after the last daily T4 injection; in experiment 2 they were killed at the time T4 was being infused via osmotic minipump; and in experiment 3 they were sacrificed 12 h after the last b.i.d. (twice daily) injection of T4. In all experiments the MH groups were prepared by maternal Tx. Sample collection On the 21st d of pregnancy, the dams were killed by decapitation and trunk blood was collected. The abdomen was then rapidly opened and AF was obtained by amniocentesis from the amniotic sac of each fetus and combined into one pool for each litter. The fetuses were then quickly delixvered by hv sterotomy, decapitated, and the trunk blood from each fetus collected and combined into one pool for each litter. Samples were stored at -20°C after centrifugation.
Hormone analyses. Serum and AF T4 and T3 concentrations were measured by radioimmunoassay (21) . rT3 was measured by radioimmunoassay using anti-rT3 antibody supplied by Dr. Sidney Leskowitz (Tufts University, Boston, Mass.) in a final dilution of 1/2,800. 125I-labeled rT3 was purchased from New England Nuclear (Boston, Mass.). Labeled rT3 was displaced from anti-rT3 antibody in a semilogarithmic fashion with the intercept at 50% displacement being 85 ng/dl. The crossreaction of 3,3'T2,T3, and T4 was 0.5, 0.03, and 0.12%, respectively. In each assay the least detectable concentration of rT3 was considered to be that giving a response 2 SD away from the 0 dose. To correct for serum and amniotic fluid effects on the assay, hormone-free rat serum or amniotic fluid prepared by charcoal extrac- When all values in a group were undetectable, the mean value assigned to the group was the value for the lower limit of detectability of the assay. Numbers in parentheses represent number of AF specimens in each group. tion were added to the respective standard curves in amounts identical to that used for the unknown samples. Serum and AF TSH was measured by radioimmunoassay using materials kindly supplied by the Hormone Distribution Officer, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Md. All assays were performed in duplicate and all samples from each experiment for each hormone were assayed concurrently. All results are expressed as the mean+SEM. In those assays in which some values were detectable and a minority of samples were below the sensitivity of the assay, the undetectable samples were assigned a value at the lower limit of sensitivity.
Statistical analyses. The data was analyzed by Kendall's test with Fisher's corrections for multiple comparisons when comparisons were made between groups in which hormone concentrations were undetectable (22) . When hormone concentrations were all detectable, values were analyzed by one way analysis of variance followed by the NewmanKeuls test to detect differences of means (22) .
RESULTS
The results are summarized in Tables II-V Fetal thyroid status. Fetal hypothyroidism was present in the MFH and FH groups since fetal serum TSH was significantly elevated in these groups as compared to C group rats. In this and subsequent experiments, T4 and T3 were not detectable in fetal serum in any group, including the normal C group. Therefore, fetal serum T4 and T3 measurements could not be used to characterize fetal thyroid status. In the MH group there was no evidence of fetal hypothyroidism because fetal serum TSH concentrations in the MH and C groups were similar. The degree of fetal Maternal thyroid status. As in experiment 1, analysis of maternal serum T4, T3, and TSH documented the presence of maternal hypothyroidism in the MFH and MH groups. In contrast to experiment 1, maternal serum TSH concentrations in these groups did not differ significantly. Maternal hypothyroidism was present in the FH group since the serum T3 concentration was significantly lower and the serum TSH concentration significantly elevated in the FH as compared to the C group. However, maternal serum T4 concentrations in the FH and C groups were not significantly different from each other.
Fetal thyroid status. The treatment regimen induced a similar degree of fetal hypothyroidism in the MFH and FH groups in that fetal serum TSH concentrations were equally elevated. As in experiment 1, there was no evidence of fetal hypothyroidism in the MH group in that the fetal serum TSH concentration in this group was normal.
Maternal serum rT3. rT3 concentrations ranged from undetectable to 41.5 ng/dl in the C group and were undetectable in the other three groups.
Fetal serum rT3. As noted in experiment 1, the fetal serum rT3 concentration in the MH rats was intermediate between values observed in the C group and the MFH group and was significantly lower in the MFH as compared to the MH group (P < 0.01). However, unlike experiment 1, the fetal serum rT3 concentration was not decreased in the FH group. AF rT3. As in experiment 1, AF rT3 was normal in the FH group and markedly decreased in the MH and MFH groups. Unlike experiment 1, where AF rT3 was undetectable in these latter two groups, AF rT3 was detectable and significantly higher in the MH as compared with the MFH rats (MH, 13 .5+0.8 vs. MFH, 8 .4±+0.9, P < 0.05). 
DISCUSSION
Models of maternal hypothyroidism, fetal hypothyroidism, and combined maternal-fetal hypothyroidism have been described in the rat. Combined maternalfetal hypothyroidism in MMI-treated dams (experiment 1) was confirmed by the presence ofundetectable T4, markedly reduced T3, and elevated TSH concentrations in maternal serum, and an elevated TSH concentration in fetal serum. MMI crosses the placenta and therefore blocks hormone formation in both the maternal and fetal thyroid. In experiment 2 maternal Tx and LID was added to the MMI regimen and in experiment 3 dams were treated with MMI and Tx. It might be expected that the degree of both maternal and fetal hypothyroidism in the MFH groups would have been greatest in experiment 2 because the most severe antithyroid regimen was used in this experiment. However, MFH/C ratios for serum TSH concentration in both maternal and fetal serum were lower in experiment 2 than in experiments 1 or 3. Induction of maternal hypothyroidism was consistently achieved by thyroidectomy. In all three experiments, thyroidectomy resulted in undetectable T4, markedly depressed T3, and four-to eightfold elevations of TSH concentration in maternal serum. Moreover, the degree of maternal hypothyroidism achieved was similar to that in the MFH groups since maternal serum TSH concentrations in the MFH group never exceeded that in the MH group. There was no evidence of fetal hypothyroidism in the MH rats.
The greatest problems were encountered in preparing a model of isolated fetal hypothyroidism. The FH groups were treated according to the MFH protocols. In addition, T4 was administered to the dams in a quantity similar to that reported by Gray and Galton (23) to be the physiological replacement dose. However, using the three T4 regimens, it was not possible to both restore serum TSH to normal in the dam and leave the elevated serum TSH in the fetus unaffected. In experiment 1 the single daily dose of 1.5 ,ug T4/100 g BW corrected maternal hypothyroidism but also decreased fetal serum TSH, although this latter value was still markedly elevated. In experiment 2, the constant infusion of 1.2 ,ug T4/100 g BW, and in experiment 3, the b.i.d. administration of 0.75 ,ug T4/ 100 g BW, did not alter fetal serum TSH concentration but maternal serum TSH remained elevated. In experiment 2, despite the fact that maternal serum T4 concentration was normal in the T4 infused hypothyroid dams, maternal serum TSH concentration was not decreased and serum T3 concentration was only partially restored to normal. These findings in the T4 infused rats were not unexpected for two reasons. First, Conners and Hedge (24) have reported that the constant infusion of a daily dose of T3 in hypothyroid rats, which normalizes the serum T3 concentration does not suppress serum TSH. The dose of infused T3 that does suppress TSH secretion is associated with an elevated serum T3 concentration. Because the only source of rT3 is T4, it was important in the present experiment to maintain a normal serum T4 concentration. This was achieved with the dose of 1.2 ,tg T4/ 100 g BW. Second, in the rat, thyroid secretion of T3 contributes far more to the serum T3 concentration than in man and the failure to restore serum T3 to normal with an infusion of T4 that normalizes the serum T4 concentration in the thyroidectomized rat reflects the absence of this thyroid contribution to circulating T3. Finally, the present observations support the findings of Tonooka and Greer (25) that there is a narrow range between the quantity of T4 required to induce minimal suppression of serum TSH and that required to suppress TSH secretion to normal in thyroidectomized rats. Since T4 and T3 were undetectable in normal fetal serum, it was not possible to use these measurements to assess the degree to which fetal hypothyroidism had been induced in the FH groups. The presence of small quantities of T4 and T3 remaining in fetal serum in the FH rats could not be ruled out. However, it is likely that significant depletion of T4 and T3 occurred since the fetal serum TSH concentration was strikingly elevated.
Various estimates have been made concerning the quantity of maternal T4 that crosses the placenta in the rat. Gray and Galton (23) concluded that both the fetal and maternal thyroid glands contribute to the maintenance of serum T4 levels in the fetus but were not able to make a quantitative estimate of the maternal contribution (23) . More recently, Dussault and Coloumbe (26) estimated that <1% of T4 in fetal serum at term is derived from the maternal thyroid. Data in the MH groups in the present study also suggest that the amount of maternal T4 that crosses the placenta under physiological conditions is negligible since 21-d fetal serum TSH concentrations were not affected by thyroidectomizing the dams early in pregnancy.
An important reason for developing these models was to determine whether alterations in AF rT3 could predict fetal hypothyroidism in the rat and to determine the source of rT3 in the AF. The present data indicates that at term the majority of AF rT3 is derived from maternal rather than fetal sources and does not provide evidence that AF rT3 can be used to predict fetal thyroid function in the rat. In the presence Maternal Thyroid Function Determines Amniotic Fluid Reverse T3 of maternal hypothyroidism, AF rT3 concentrations were strikingly reduced irrespective of fetal thyroid function. Moreover, AF rT3 was not decreased in the presence offetal hypothyroidism alone, offering further evidence that the fetal thyroid contributes little to AF rT3. Because the extent of the decrease in serum T4 concentration in the hypothyroid fetus could not be determined, complete absence of T4 in the fetus might have resulted in a decrease in AF rT3. Although absolute fetal thyroid agenesis in the rat may, therefore, be associated with reduced AF rT3 concentrations, the above data suggests that this reduction would be small.
In contrast to the findings in amniotic fluid, fetal serum rT3 concentrations were, in general, reduced and to the same degree in the presence of either maternal or fetal hypothyroidism. When both maternal and fetal hypothyroidism were present, fetal serum rT3 concentrations were even lower or undetectable. These data suggest an approximately equal contribution to serum rT3 concentration by maternal and fetal sources of T4. It is unlikely, therefore, that AF rT3 concentration is directly dependent upon fetal serum rT3.
In view of these complex findings, it is most difficult at the present time to define the mechanism(s) whereby maternal thyroid secretion of T4 directly affects the concentration of rT3 in amniotic fluid. Direct transfer of rT3 from maternal serum or by way of the fetus to the AF is unlikely, in that the constant infusion of large quantities of rT3 to MFH rats resulted in a 35-fold increase in maternal serum rT3 concentration, a twofold increase in fetal serum rT3 concentration, and only a minimal effect on AF rT3. These findings also tend to rule out a contribution to AF of fetal serum rT3, which could conceivably arise from the placental conversion of maternal T4 to rT3. Placental transfer of T4 from dam to fetus under physiologic conditions is minimal (26) , therefore it is unlikely that sufficient maternal T4 would reach the fetus and be a major source of AF rT3 generated in fetal liver or kidney. Two other possibilities remain. Direct transfer of T4 from the dam to the amniotic fluid and the conversion of this T4 or rT3 by amniotic fluid cells in the amniotic fluid, or the amniotic sac. In the sheep, evidence for in vivo and in vitro conversion of T4 to rT3 in amniotic fluid has been reported (27) . This might be possible because, in the sheep, it has been suggested that a small quantity of T4 is directly transferred from mother to the amniotic fluid (28) . The final, and most attractive hypothesis, is that maternal T4 is deiodinated to rT3 at a tissue site in the region of the maternal compartment and the amniotic sac with direct transfer of this rT3 into the amniotic fluid. A possible site for this conversion to rT3 and its subsequent transfer into the amniotic fluid is the chorion. This tissue, as demonstrated in a recent study by Murphy (29) , is metabolically active, has different enzyme systems than the placental cotyledons, is frequently adherent to the matemal decidua, and is separated from the amniotic cavity only by the thin amnion which is permeable to other hormones such as the adrenal steroids. Very preliminary data do suggest that rat and human chorion convert T4 to rT3 but not to T3 as determined by incubation of chorion homogenates with 125I-T4 and analysis of the labeled products by descending paper chromatography in hexane-tertiary amyl alcohol-2N NH3 (1:5:6, vol/vol/vol).
In summary, the present studies demonstrate that models of maternal-fetal hypothyroidism, maternal hypothyroidism, and fetal hypothyroidism, that approximate the ideal have been developed in the rat. rT3 is present in fetal rat serum and AF. The concentration is approximately fivefold lower in fetal rat serum at term than that reported in human cord blood (30) and about threefold lower in rat AF than that reported in the human at term (2) (3) (4) (5) (6) . We are unaware of any other reports demonstrating rT3 in rat amniotic fluid. It seems evident that, in the rat, AF rT3 derives primarily from maternal sources of T4. In view of these results in the rat and the recent report that AF rT3 values were not useful in predicting fetal hypothyroidism in two patients (31) , the possibility must be considered that, in man, AF rT3 does not reflect fetal thyroid status.
